Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaj Torp

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Clinical Nutrition|January 29, 2026
Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetesEllen Elise Petersen, Johanne Kragh Hansen, Nikolaj Torp, et al.
Journal of Hepatology|April 23, 2023
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjaergaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2023
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation-related markersEvelina Stankevic, Mads Israelsen, Helene Baek Juel, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Journal of Hepatology|July 6, 2025
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Johanne Kragh Hansen, Mads Israelsen, et al.
Gastroenterology|December 22, 2025
Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver DiseaseNikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
Annals of Internal Medicine|December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled TrialCamilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Clinical Nutrition|January 29, 2026
Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetesEllen Elise Petersen, Johanne Kragh Hansen, Nikolaj Torp, et al.
Journal of Hepatology|April 23, 2023
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver diseaseMaria Kjaergaard, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2023
Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation-related markersEvelina Stankevic, Mads Israelsen, Helene Baek Juel, et al.
Alimentary Pharmacology & Therapeutics|August 11, 2025
MetALD: Diagnosis and Prognosis With Non-Invasive TestsNikolaj Torp, Mads Israelsen, Stine Johansen, et al.
Journal of Hepatology|July 6, 2025
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the communityCamilla Dalby Hansen, Johanne Kragh Hansen, Mads Israelsen, et al.
Gastroenterology|December 22, 2025
Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver DiseaseNikolaj Torp, Stine Johansen, Ellen Lyngbeck Jensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 14, 2026
Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALDEllen Lyngbeck Jensen, Maja Thiele, Nikolaj Torp, et al.
Annals of Internal Medicine|December 12, 2022
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled TrialCamilla Dalby Hansen, Eva-Marie Gram-Kampmann, Johanne Kragh Hansen, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort studyKatrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
Cell|November 14, 2024
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associationsSuguru Nishijima, Evelina Stankevic, Oliver Aasmets, et al.
Pageof 5